Hamidreza Ashayeri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hamidreza Ashayeri has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Ali Jafarizadeh
Nikookari Eye Center, Tabriz University of Medical Sciences, Tabriz, Iran
7 shared publications - Hanieh Salehi-Pourmehr
Tabriz University of Medical Sciences
5 shared publications - Ali Shushtari
Mazandaran University of Medical Sciences
3 shared publications - Hadi Vahedi
Nikookari Eye Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 shared publications - Sakineh Hajebrahimi
Research Center for Evidence‐based Medicine, Iranian EBM Centre: A Joanna Briggs Institute (JBI) Center of Excellence Tabriz University of Medical Sciences Tabriz Iran
3 shared publications - Amir Bahrami
Endocrine Research Center Tabriz University of Medical Sciences Tabriz Iran
2 shared publications
Latest Publications
- Open Access
Uveal and cutaneous melanoma share a common mutation with distinct prognostic implications: A bioinformatic study
What was known before: Uveal melanoma (UM) and cutaneous melanoma (CM) arise from a common melanocytic lineage but exhibit distinct genetic landscapes, biological behavior, and clinical outcomes. Pigmentation-related genes, including IRF4 and HERC2, have been implicated in melanoma susceptibility and prognosis; however, the extent of shared genetic variants between UM and CM has remained unclear. Previous studies have primarily investigated UM and CM separately, leaving limited understanding of their common genetic architecture and potential shared prognostic biomarkers. What this study adds: This bioinformatic analysis identified only two shared validated genetic variants between UM and CM across publicly available databases: rs12203592 (IRF4) and rs12913832 (HERC2). Protein–protein interaction analysis demonstrated that IRF4 and OCA2 directly interact with HERC2, supporting a biologically plausible pigmentation-related pathway linking the two melanoma subtypes. The findings suggest that IRF4 may represent a common prognostic biomarker across both UM and CM, while combined assessment of IRF4 and HERC2 could improve future risk stratification and facilitate more personalized therapeutic approaches. Background: Uveal melanoma (UM) and cutaneous melanoma (CM) both originate from the same cell line. This proposes the possibility of a shared mechanism between entities, requiring explicit investigation. Methods: Data from GWAS Catalog and DisGeNET were used to identify shared variation-disease associations (VDAs) between UM and CM. The results were validated using the Ensembl database. In the next step, the STRING database was used to identify the protein– protein interaction. Results: Subsequently, 109 unique VDAs were identified for UM and 880 for CM. However, only 2 VDAs were found to be shared among UM and CM in different ethnic groups. These shared VDAs were rs12203592 of the IRF4 gene, rs12913832 of the HECT and RLD domain-containing E3 ubiquitin protein ligase 2 (HERC2) gene. Notably, PPI network assessment through STRING showcased that OCA2 and IRF4 directly interacted with HERC2. Conclusion: While HERC2 acts as a poor prognostic factor in uveal melanoma, IRF4 status is a key prognostic indicator in both UM and CM. Identifying IRF4 allele contributions enables a better understanding of melanoma pathogenesis and fosters the development of disease-specific approaches.
Open AccessUveal and cutaneous melanoma share a common mutation with distinct prognostic implications: A bioinformatic study
What was known before: Uveal melanoma (UM) and cutaneous melanoma (CM) arise from a common melanocytic lineage but exhibit distinct genetic landscapes, biological behavior, and clinical outcomes. Pigmentation-related genes, including IRF4 and HERC2, have been implicated in melanoma susceptibility and prognosis; however, the extent of shared genetic variants between UM and CM has remained unclear. Previous studies have primarily investigated UM and CM separately, leaving limited understanding of their common genetic architecture and potential shared prognostic biomarkers. What this study adds: This bioinformatic analysis identified only two shared validated genetic variants between UM and CM across publicly available databases: rs12203592 (IRF4) and rs12913832 (HERC2). Protein–protein interaction analysis demonstrated that IRF4 and OCA2 directly interact with HERC2, supporting a biologically plausible pigmentation-related pathway linking the two melanoma subtypes. The findings suggest that IRF4 may represent a common prognostic biomarker across both UM and CM, while combined assessment of IRF4 and HERC2 could improve future risk stratification and facilitate more personalized therapeutic approaches. Background: Uveal melanoma (UM) and cutaneous melanoma (CM) both originate from the same cell line. This proposes the possibility of a shared mechanism between entities, requiring explicit investigation. Methods: Data from GWAS Catalog and DisGeNET were used to identify shared variation-disease associations (VDAs) between UM and CM. The results were validated using the Ensembl database. In the next step, the STRING database was used to identify the protein– protein interaction. Results: Subsequently, 109 unique VDAs were identified for UM and 880 for CM. However, only 2 VDAs were found to be shared among UM and CM in different ethnic groups. These shared VDAs were rs12203592 of the IRF4 gene, rs12913832 of the HECT and RLD domain-containing E3 ubiquitin protein ligase 2 (HERC2) gene. Notably, PPI network assessment through STRING showcased that OCA2 and IRF4 directly interacted with HERC2. Conclusion: While HERC2 acts as a poor prognostic factor in uveal melanoma, IRF4 status is a key prognostic indicator in both UM and CM. Identifying IRF4 allele contributions enables a better understanding of melanoma pathogenesis and fosters the development of disease-specific approaches.
- Open Access
- 10 August 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1) , 479
Ocular findings in pediatric candidates for cochlear implantation with bilateral sensorineural hearing loss: a brief report from northwestern Iran
Background: The presence of ocular abnormalities in patients with sensorineural hearing loss (SNHL) may affect children’s developmental milestones due to impairment of primary sensory inputs. This study aimed to evaluate the prevalence of different ophthalmologic abnormalities in pediatric patients with bilateral SNHL who were candidates for cochlear implantation (CI). Methods: We performed a retrospective medical chart review of 261 pediatric patients under 13 years of age with bilateral SNHL who were candidates for CI and were evaluated at a tertiary cochlear implantation referral center in northwestern Iran between March 21, 2017, and June 20, 2025. Ophthalmologic findings were assessed as the main outcome measures. Results: The overall prevalence of ocular findings was 19.5%. Cardiac abnormalities were observed in 17.6% of patients, and refractive errors were identified in 8.4%. Jaundice was the most common prenatal complication, and 36.8% of patients had a history of neurologic complications. Ocular, cardiologic, and neurologic manifestations occurred independently of one another, with no significant pairwise co-occurrence among the three systems. Conclusions: Our findings highlight the need for a multidisciplinary approach in candidates for CI with bilateral SNHL. Comprehensive ophthalmologic evaluation is essential in this population, with particular attention to refractive errors, ocular alignment, and fundus assessment. Because ocular, cardiologic, and neurologic findings occurred independently in the exploratory analysis, screening for each system should be pursued comprehensively and in parallel rather than selectively guided by findings in another system. Trial registration: Not applicable.
- 10 August 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1) , 479
Open AccessOcular findings in pediatric candidates for cochlear implantation with bilateral sensorineural hearing loss: a brief report from northwestern Iran
Background: The presence of ocular abnormalities in patients with sensorineural hearing loss (SNHL) may affect children’s developmental milestones due to impairment of primary sensory inputs. This study aimed to evaluate the prevalence of different ophthalmologic abnormalities in pediatric patients with bilateral SNHL who were candidates for cochlear implantation (CI). Methods: We performed a retrospective medical chart review of 261 pediatric patients under 13 years of age with bilateral SNHL who were candidates for CI and were evaluated at a tertiary cochlear implantation referral center in northwestern Iran between March 21, 2017, and June 20, 2025. Ophthalmologic findings were assessed as the main outcome measures. Results: The overall prevalence of ocular findings was 19.5%. Cardiac abnormalities were observed in 17.6% of patients, and refractive errors were identified in 8.4%. Jaundice was the most common prenatal complication, and 36.8% of patients had a history of neurologic complications. Ocular, cardiologic, and neurologic manifestations occurred independently of one another, with no significant pairwise co-occurrence among the three systems. Conclusions: Our findings highlight the need for a multidisciplinary approach in candidates for CI with bilateral SNHL. Comprehensive ophthalmologic evaluation is essential in this population, with particular attention to refractive errors, ocular alignment, and fundus assessment. Because ocular, cardiologic, and neurologic findings occurred independently in the exploratory analysis, screening for each system should be pursued comprehensively and in parallel rather than selectively guided by findings in another system. Trial registration: Not applicable.
- Open Access
- 7 August 2026
- Published by Elsevier in Acta Psychologica
- Vol. 269, 107597
Sensitivity and specificity of the CANTAB Paired Associates Learning test for identifying mild cognitive impairment
- 7 August 2026
- Published by Elsevier in Acta Psychologica
- Vol. 269, 107597
Open AccessSensitivity and specificity of the CANTAB Paired Associates Learning test for identifying mild cognitive impairment
- Open Access
Timing of Radiotherapy in Uveal Melanoma: A SEER-Based Comparison of Preoperative, Postoperative, and Intraoperative Approaches
Purpose: To analyze the effect of radiotherapy timing relative to surgery on patients’ survival and mortality rates in uveal melanoma (UM). Design: Retrospective cohort study using registry data from the Surveillance, Epidemiology, and End Results (SEER) database. Subjects: A total of 1,198 patients with UM were extracted from the SEER database and divided into three groups: preoperative radiotherapy, intraoperative radiotherapy (IORT), and postoperative radiotherapy. Methods: UM cases were extracted from the SEER database. Survival curves were generated based on the Kaplan-Meier method. An extended Cox regression was used to estimate the cancer-specific and all-cause mortality. Main Outcome Measures: Overall survival (including median survival) and hazard reductions for cancer-specific and all-cause mortality. Results: Preoperative radiotherapy revealed the highest median survival (4.93 years), followed by postoperative radiotherapy (4.76 years), and IORT (4.02 years). The preoperative strategy reduced the hazard of all-cause mortality by 42%, 50%, and 60% at 5-, 7-, and 10-year follow-up, respectively, compared with IORT. Findings were consistent in the cancer-specific sensitivity analysis (45%, 53%, and 62% reductions at the same time points). However, postoperative radiotherapy did not significantly reduce the cancer-specific mortality in comparison to IORT. Conclusions: Preoperative radiotherapy was associated with higher median overall survival and lower all-cause and cancer-specific mortality than IORT over 10 years of follow-up. Postoperative radiotherapy showed intermediate outcomes that did not differ significantly from IORT. Prospective studies with more detailed data on the temporal relation of radiotherapy timing and surgery are needed to confirm these findings.
Open AccessTiming of Radiotherapy in Uveal Melanoma: A SEER-Based Comparison of Preoperative, Postoperative, and Intraoperative Approaches
Purpose: To analyze the effect of radiotherapy timing relative to surgery on patients’ survival and mortality rates in uveal melanoma (UM). Design: Retrospective cohort study using registry data from the Surveillance, Epidemiology, and End Results (SEER) database. Subjects: A total of 1,198 patients with UM were extracted from the SEER database and divided into three groups: preoperative radiotherapy, intraoperative radiotherapy (IORT), and postoperative radiotherapy. Methods: UM cases were extracted from the SEER database. Survival curves were generated based on the Kaplan-Meier method. An extended Cox regression was used to estimate the cancer-specific and all-cause mortality. Main Outcome Measures: Overall survival (including median survival) and hazard reductions for cancer-specific and all-cause mortality. Results: Preoperative radiotherapy revealed the highest median survival (4.93 years), followed by postoperative radiotherapy (4.76 years), and IORT (4.02 years). The preoperative strategy reduced the hazard of all-cause mortality by 42%, 50%, and 60% at 5-, 7-, and 10-year follow-up, respectively, compared with IORT. Findings were consistent in the cancer-specific sensitivity analysis (45%, 53%, and 62% reductions at the same time points). However, postoperative radiotherapy did not significantly reduce the cancer-specific mortality in comparison to IORT. Conclusions: Preoperative radiotherapy was associated with higher median overall survival and lower all-cause and cancer-specific mortality than IORT over 10 years of follow-up. Postoperative radiotherapy showed intermediate outcomes that did not differ significantly from IORT. Prospective studies with more detailed data on the temporal relation of radiotherapy timing and surgery are needed to confirm these findings.
- Open Access
- 25 July 2026
- Published by Elsevier in American Journal of Medicine Open
- Vol. 16, 100139
A Rare Behavior of Microprolactinoma with Significant Fluctuation in Size During Pregnancy
- 25 July 2026
- Published by Elsevier in American Journal of Medicine Open
- Vol. 16, 100139
Open AccessA Rare Behavior of Microprolactinoma with Significant Fluctuation in Size During Pregnancy
- 23 March 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 30 (4)
Bullous Herpes Dermatitis
- 23 March 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 30 (4)
Bullous Herpes Dermatitis
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Immunology
- Vol. 2026 (1) , 8573882
Serine/Threonine Kinase 4 Deficiency Caused by a Potential Novel c.248del, p.Pro83Leufs∗3 Mutation: A Case Report
Background: Serine/threonine kinase 4 (STK4) deficiency is one of the rare causes of combined immunodeficiency (CID). In this study, we report a novel mutation causing STK4 deficiency, which presents with chronic pyelonephritis, an uncommon presentation. Case Presentation: A 10‐year‐old female with an incidental mass in the kidney extending to the liver, night sweats, and fever was presented. To reduce the mass effect and rule out the possibility of malignancy, the patient underwent a nephrectomy, and a biopsy revealed chronic pyelonephritis. After surgery, due to the persistent leukopenia, the chance of an inborn error of immunity was considered. The patient was referred to the immunology clinic. Investigations: Immunophenotyping revealed low levels of CD3 and CD4. The antibody titer did not show a significant rise after receiving diphtheria and tetanus vaccines. Whole‐exome sequencing was performed, and a novel homozygous c.248del, p.Pro83Leufs ∗ 3 variant was reported in the STK4 gene. The presence of this variant in parents was also confirmed with Sanger sequencing. Conclusion: STK4 deficiency is a rare cause of CID characterized by susceptibility to recurrent infections. Our case shows immune dysfunction manifested as a complex inflammatory syndrome, featuring an abdominal mass that mimics malignancy, expanding the recognized clinical spectrum of this condition.
- 1 January 2026
- Published by Wiley in Case Reports in Immunology
- Vol. 2026 (1) , 8573882
Open AccessSerine/Threonine Kinase 4 Deficiency Caused by a Potential Novel c.248del, p.Pro83Leufs∗3 Mutation: A Case Report
Background: Serine/threonine kinase 4 (STK4) deficiency is one of the rare causes of combined immunodeficiency (CID). In this study, we report a novel mutation causing STK4 deficiency, which presents with chronic pyelonephritis, an uncommon presentation. Case Presentation: A 10‐year‐old female with an incidental mass in the kidney extending to the liver, night sweats, and fever was presented. To reduce the mass effect and rule out the possibility of malignancy, the patient underwent a nephrectomy, and a biopsy revealed chronic pyelonephritis. After surgery, due to the persistent leukopenia, the chance of an inborn error of immunity was considered. The patient was referred to the immunology clinic. Investigations: Immunophenotyping revealed low levels of CD3 and CD4. The antibody titer did not show a significant rise after receiving diphtheria and tetanus vaccines. Whole‐exome sequencing was performed, and a novel homozygous c.248del, p.Pro83Leufs ∗ 3 variant was reported in the STK4 gene. The presence of this variant in parents was also confirmed with Sanger sequencing. Conclusion: STK4 deficiency is a rare cause of CID characterized by susceptibility to recurrent infections. Our case shows immune dysfunction manifested as a complex inflammatory syndrome, featuring an abdominal mass that mimics malignancy, expanding the recognized clinical spectrum of this condition.
- Open Access
- 30 November 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (12)
Diagnostic Challenges of Adrenal Venous Sampling for Primary Hyperaldosteronism in a Patient With Subclinical Cushing's Syndrome: A Case Report
Hypertension is a significant comorbidity in the New World, and its prevalence is rising. Around 5%–10% of cases with hypertension have secondary hypertension. Adrenal gland disease is among the common causes of secondary hypertension. We present a 57‐year‐old male with uncontrolled hypertension and a history of intracranial hemorrhage. The lab evaluation of the patient revealed a K+ of 3.8 mEq/L, Na + of 138 mEq/L, Renin of 2.6 mIU/L, Aldosterone of 47.3 ng/dL, consistent with primary hyperaldosteronism (PHA). The patient's abdominal computed tomography (CT) revealed an adrenal mass measuring 21 mm in the right adrenal gland. However, the adrenal‐vein sampling showed that the mass is probably not the source of aldosterone excess, and a possible diagnosis of adrenal hyperplasia was made. To investigate the adrenal incidentaloma, the 1 mg overnight dexamethasone suppression test was performed. The 8 a.m. cortisol and ACTH levels were reported to be 5 microg/dL and 3.2 pg/mL, and a diagnosis of mild autonomous hypercortisolism was also made. CT is not an accurate method to differentiate between an adrenal‐producing adenoma and bilateral idiopathic adrenal hyperplasia. Even in cases where a visible mass is detected on CT, patients aged 35 or older need to be evaluated for the cause of PHA.
- 30 November 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (12)
Open AccessDiagnostic Challenges of Adrenal Venous Sampling for Primary Hyperaldosteronism in a Patient With Subclinical Cushing's Syndrome: A Case Report
Hypertension is a significant comorbidity in the New World, and its prevalence is rising. Around 5%–10% of cases with hypertension have secondary hypertension. Adrenal gland disease is among the common causes of secondary hypertension. We present a 57‐year‐old male with uncontrolled hypertension and a history of intracranial hemorrhage. The lab evaluation of the patient revealed a K+ of 3.8 mEq/L, Na + of 138 mEq/L, Renin of 2.6 mIU/L, Aldosterone of 47.3 ng/dL, consistent with primary hyperaldosteronism (PHA). The patient's abdominal computed tomography (CT) revealed an adrenal mass measuring 21 mm in the right adrenal gland. However, the adrenal‐vein sampling showed that the mass is probably not the source of aldosterone excess, and a possible diagnosis of adrenal hyperplasia was made. To investigate the adrenal incidentaloma, the 1 mg overnight dexamethasone suppression test was performed. The 8 a.m. cortisol and ACTH levels were reported to be 5 microg/dL and 3.2 pg/mL, and a diagnosis of mild autonomous hypercortisolism was also made. CT is not an accurate method to differentiate between an adrenal‐producing adenoma and bilateral idiopathic adrenal hyperplasia. Even in cases where a visible mass is detected on CT, patients aged 35 or older need to be evaluated for the cause of PHA.
- Open Access
- 24 October 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 1-12
Therapeutic hypothermia in patients with traumatic brain injury: an umbrella review
Background: Therapeutic hypothermia (TH) is an intervention conducted to reduce brain damage in neonatal asphyxia and postcardiac arrest patients. Traumatic brain injury (TBI) dysregulates cerebral blood flow and causes ischemic brain damage. TH could lower brain damage by reducing the metabolism rate and need for oxygen. In this umbrella review, we aim to investigate different aspects of TH intervention in TBI patients. Methods: We searched MEDLINE, Scopus, Embase, Cinahl, Epistemonikos, Cochrane Library, Web of Science, and Google Scholar for relevant systematic reviews until August 03, 2025. Then, studies entered the screening process, and systematic reviews of TH`s effect on TBI patients were included. We excluded studies without any quality assessments. Data for mortality, favorable and unfavorable neurologic outcomes, and possible complications of TH were extracted from the included studies. We avoided meta-analysis due to the vast heterogeneity between the studies’ methodologies. Results: Of the 1466 studies identified from the primary search, 30 met our inclusion criteria. According to the JBI critical appraisal tool for systematic reviews, 29 studies were of high quality, and 1 was of medium quality. Studies had different methodologies, such as different induction methods and durations, different age groups, target temperatures, and rewarming rates. Mortality was the most common outcome assessed by the studies. Morbidity was assessed as either favorable or unfavorable neurological outcomes at a follow-up of 1,3,6,12,24 months. Pneumonia was the most investigated side-effect of TH, and most studies reported a greater chance of pneumonia in the TH group. Other investigated complications of TH were electrolyte abnormalities, coagulopathy, and arrhythmia. Conclusion: Studies have shown controversial results regarding the effect of TH on mortality and morbidity. Differences in the target population, hypothermia protocol, and quality of included studies may be responsible for part of this controversy. Some of the important parameters that may affect the results are the age of TBI patients, the use of barbiturates, target TH temperature, rewarming rates, and method of cooling. Additionally, the subgroup analysis of high-quality studies differed from the pooled analysis provided by each study. More high-quality studies with specific protocols are needed to better understand TH’s role in TBI patients.
- 24 October 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 1-12
Open AccessTherapeutic hypothermia in patients with traumatic brain injury: an umbrella review
Background: Therapeutic hypothermia (TH) is an intervention conducted to reduce brain damage in neonatal asphyxia and postcardiac arrest patients. Traumatic brain injury (TBI) dysregulates cerebral blood flow and causes ischemic brain damage. TH could lower brain damage by reducing the metabolism rate and need for oxygen. In this umbrella review, we aim to investigate different aspects of TH intervention in TBI patients. Methods: We searched MEDLINE, Scopus, Embase, Cinahl, Epistemonikos, Cochrane Library, Web of Science, and Google Scholar for relevant systematic reviews until August 03, 2025. Then, studies entered the screening process, and systematic reviews of TH`s effect on TBI patients were included. We excluded studies without any quality assessments. Data for mortality, favorable and unfavorable neurologic outcomes, and possible complications of TH were extracted from the included studies. We avoided meta-analysis due to the vast heterogeneity between the studies’ methodologies. Results: Of the 1466 studies identified from the primary search, 30 met our inclusion criteria. According to the JBI critical appraisal tool for systematic reviews, 29 studies were of high quality, and 1 was of medium quality. Studies had different methodologies, such as different induction methods and durations, different age groups, target temperatures, and rewarming rates. Mortality was the most common outcome assessed by the studies. Morbidity was assessed as either favorable or unfavorable neurological outcomes at a follow-up of 1,3,6,12,24 months. Pneumonia was the most investigated side-effect of TH, and most studies reported a greater chance of pneumonia in the TH group. Other investigated complications of TH were electrolyte abnormalities, coagulopathy, and arrhythmia. Conclusion: Studies have shown controversial results regarding the effect of TH on mortality and morbidity. Differences in the target population, hypothermia protocol, and quality of included studies may be responsible for part of this controversy. Some of the important parameters that may affect the results are the age of TBI patients, the use of barbiturates, target TH temperature, rewarming rates, and method of cooling. Additionally, the subgroup analysis of high-quality studies differed from the pooled analysis provided by each study. More high-quality studies with specific protocols are needed to better understand TH’s role in TBI patients.